In hepatocellular carcinoma, EMT is driven by IGF1-induced activation of the transcription factor STAT5 [66], while in prostate cancer cells, IGF1 stimulation up-regulates ZEB1, a zinc finger homeodomain transcriptional repressor. Here, IGF1 is linked to prostate cancer.